SignatureFD’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Other funds holding PTGX
SignatureFD's PTGX Position: Q3 2026 in Review
SignatureFD increased its Protagonist Therapeutics (PTGX) stake by 6.8% in Q3 2026, buying an estimated $3.14K and bringing the position to 344 shares worth $48.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1976.
SignatureFD first reported a position in PTGX in Q3 2020 and has held it in 16 quarters since. 379 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.
- SignatureFD held 344 shares of Protagonist Therapeutics worth $48.5K as of Q3 2026.
- SignatureFD bought 22 Protagonist Therapeutics shares in Q3 2026, an estimated $3.14K.
- Protagonist Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #1976 holding.
- SignatureFD first reported a position in Protagonist Therapeutics in Q3 2020 and has held it in 16 quarters since.
- 379 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.
Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.